Remote Patient Monitoring Extends Survival and Improves Quality of Life

by | Jun 5, 2017 | News

ASCO 2017 ANNUAL MEETING – Web-based tool provides alerts to clinicians and demonstrates major benefits including longer survival rates for patients with metastatic cancer.

In a new landmark study, patients experienced longer survival rates and improved quality of life while using a web-based tool to self-report their symptoms. The randomized clinical trial was conducted involving 766 patients receiving chemotherapy. Patients who regularly self-reported their symptoms using the web-based tool lived a median of 5 months longer than those assigned to usual care. In addition, patients reported improved quality of life and experienced fewer emergency room visits and hospitalizations. The study results were presented by Ethan Basch, MD, MSc in the June 4 plenary session of the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, and published simultaneously online in JAMA. 1, 2

“This study is a milestone for the entire remote patient monitoring industry, and it further validates the vision we founded our company upon nearly 4 years ago,” said Raj Agarwal, CEO and President of Medocity. “Real world evidence such as this clearly demonstrates the power of virtual care technology to positively impact patient outcomes and improve their quality-of-life.”


  1. Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA2017
  2. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
    Ethan Basch, Allison M. Deal, Mark G. Kris, Howard I. Scher, Clifford A. Hudis, Paul Sabbatini, Lauren Rogak, Antonia V. Bennett, Amylou C. Dueck, Thomas M. Atkinson, Joanne F. Chou, Dorothy Dulko, Laura Sit, Allison Barz, Paul Novotny, Michael Fruscione, Jeff A. Sloan, and Deborah Schrag. Journal of Clinical Oncology 2016 34:6, 557-565

About Medocity

Medocity, headquartered in Parsippany, New Jersey, is a recognized leader in comprehensive virtual care products and services including chronic condition management, televisits, and remote patient monitoring. Our unique, innovative technology combines multiple telehealth capabilities onto a single, integrated care coordination and management platform, along with robust clinical intelligence including rules-based algorithms, alerts and decision support tools to help drive earlier detection and proactive interventions.

The Medocity platform is specifically designed to enable and improve patient-centered care delivered outside the hospital setting, particularly for patients at home who have chronic conditions responsible for more than 80% of the nation’s annual healthcare spend. By promoting patient-clinician engagement through shared connectivity and virtual technology, we enable rich, real-time interactions between patients, clinicians, care professionals and support teams.Virtual care. Real outcomes.™